Lee CK - Search Results

1

Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor.

Tjokrowidjaja A, Friedlander ML, Ledermann JA, Coleman RL, Mirza MR, Matulonis UA, Pujade-Lauraine E, Lord SJ, Scott CL, Goble S, York W, Lee CK; Gynecologic Cancer Intergroup Meta-Analysis Committee. Tjokrowidjaja A, et al. Among authors: lee ck. J Clin Oncol. 2024 Apr 10;42(11):1301-1310. doi: 10.1200/JCO.23.01182. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215359

2

Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy.

Lee CK, Pires de Miranda M, Ledermann JA, Ruiz de Elvira MC, Nelstrop AE, Lambert HE, Rustin GJ, Trask CW. Lee CK, et al. Eur J Cancer. 1999 May;35(5):727-32. doi: 10.1016/s0959-8049(99)00011-8. Eur J Cancer. 1999. PMID: 10505032

3

Molecular biomarkers to individualise treatment: assessing the evidence.

Lee CK, Lord SJ, Coates AS, Simes RJ. Lee CK, et al. Med J Aust. 2009 Jun 1;190(11):631-6. doi: 10.5694/j.1326-5377.2009.tb02592.x. Med J Aust. 2009. PMID: 19485842 Review.

4

Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias.

Lee CK, Lord SJ, Stockler MR, Coates AS, Gebski V, Simes RJ. Lee CK, et al. Eur J Cancer. 2010 Feb;46(3):541-8. doi: 10.1016/j.ejca.2009.11.013. Epub 2009 Dec 23. Eur J Cancer. 2010. PMID: 20036117

5

Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.

Lee CK, Stockler MR, Coates AS, Gebski V, Lord SJ, Simes RJ; Australian New Zealand Breast Cancer Trials Group. Lee CK, et al. Br J Cancer. 2010 Apr 27;102(9):1341-7. doi: 10.1038/sj.bjc.6605649. Epub 2010 Apr 13. Br J Cancer. 2010. PMID: 20389302 Free PMC article.

6

A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.

Lee CK, Hudson M, Stockler M, Coates AS, Ackland S, Gebski V, Lord S, Friedlander M, Boyle F, Simes RJ. Lee CK, et al. Breast Cancer Res Treat. 2011 Sep;129(2):467-76. doi: 10.1007/s10549-011-1471-9. Epub 2011 Mar 29. Breast Cancer Res Treat. 2011. PMID: 21445568

7

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.

Lee CK, Gurney H, Brown C, Sorio R, Donadello N, Tulunay G, Meier W, Bacon M, Maenpaa J, Petru E, Reed N, Gebski V, Pujade-Lauraine E, Lord S, Simes RJ, Friedlander M. Lee CK, et al. Br J Cancer. 2011 Jul 26;105(3):360-5. doi: 10.1038/bjc.2011.256. Epub 2011 Jul 12. Br J Cancer. 2011. PMID: 21750553 Free PMC article. Clinical Trial.

8

Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer.

Lee CK, Friedlander M, Brown C, Gebski VJ, Georgoulopoulos A, Vergote I, Pignata S, Donadello N, Schmalfeldt B, Delva R, Mirza MR, Sauthier P, Pujade-Lauraine E, Lord SJ, Simes RJ. Lee CK, et al. J Natl Cancer Inst. 2011 Sep 7;103(17):1338-42. doi: 10.1093/jnci/djr282. Epub 2011 Aug 11. J Natl Cancer Inst. 2011. PMID: 21840849

9

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.

Lee CK, Simes RJ, Brown C, Lord S, Wagner U, Plante M, Vergote I, Pisano C, Parma G, Burges A, Bourgeois H, Högberg T, Bentley J, Angleitner-Boubenizek L, Ferrero A, Richter B, Hirte H, Gebski V, Pfisterer J, Pujade-Lauraine E, Friedlander M. Lee CK, et al. Br J Cancer. 2011 Oct 11;105(8):1144-50. doi: 10.1038/bjc.2011.364. Epub 2011 Sep 13. Br J Cancer. 2011. PMID: 21915127 Free PMC article.

10

Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.

Verry H, Lord SJ, Martin A, Gill G, Lee CK, Howard K, Wetzig N, Simes J. Verry H, et al. Among authors: lee ck. Br J Cancer. 2012 Mar 13;106(6):1045-52. doi: 10.1038/bjc.2012.62. Br J Cancer. 2012. PMID: 22415293 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,188 results

Search Page